Clinical TrialsSearch results
Number of results: 1192
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Multicenter, Randomized, Parallel-group, Double-blind,Two-arm Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared With Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive With Systemic Sclerosis
- Systemic Sclerosis, Scleroderma
- Ageishi Yuji
- 2023-11-11
Other
- Phase II study of biweekly cetuximab plus irinotecan for unresectable colorectal cancer
- Unresectable colorectal cancer
- Aichi Cancer Center Hospital
- 2009-05-11
Other
- Phase IIb/III Clinical Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy
- Idiopathic triglyceride deposit cardiomyovasculopathy
- Akita Yasuhiko
- 2022-02-19
Recruiting
- An Expanded Access Program of CNT-01 in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy
- Idiopathic triglyceride deposit cardiomyovasculopathy
- Akita Yasuhiko
- 2023-01-30
Other
- Randomized multi-institutional study for effectiveness of intervention on life style in obese patients with fasting hyperglycemia or abnormal glucose tolerance test.
- Diabetes mellitus (Pre-diabetes )
- All Japan Federation of Social Insurance Associations
- 2009-05-12
Other
- Japanese Research of Cholesterol and Diabetes Mellitus
- Diabetics and the patients with impaired glucose tolerance
- AMED
- 2006-11-10
Other
- Phase 3 Study to Evaluate Efficacy, Safety, PK, and PD of SC Natalizumab in Japanese Participants With RRMS
- Relapsing-Remitting Multiple Sclerosis
- Amir Hadi Maghzi
- 2021-12-26
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- The renoprotective effects of ARB in patients with IgA nephropathy : multicenter,radomized trial
- IgA nephropathy
- ARB therapeutic society of IgA nephropathy
- 2006-03-31
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07